Published in Mol Cell Biol on November 01, 1998
Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol (2010) 9.35
Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev (1999) 7.58
Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res (2004) 7.50
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A (2001) 5.02
Cloning of a mammalian transcriptional activator that binds unmethylated CpG motifs and shares a CXXC domain with DNA methyltransferase, human trithorax, and methyl-CpG binding domain protein 1. Mol Cell Biol (2000) 3.44
methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol (2012) 3.44
Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev (2001) 3.41
Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A (2002) 3.29
Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human beta-globin locus. Genes Dev (2000) 3.27
Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation. Genes Dev (1999) 3.19
Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell (2011) 3.19
Function and information content of DNA methylation. Nature (2015) 3.09
MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol Cell Biol (2006) 3.05
The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev (2001) 2.91
NoRC--a novel member of mammalian ISWI-containing chromatin remodeling machines. EMBO J (2001) 2.67
Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells. Immunity (2011) 2.49
The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev (2001) 2.48
Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb Perspect Biol (2012) 2.42
Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet (1999) 2.42
The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res (2003) 2.41
Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. EMBO J (2002) 2.40
Genomic imprinting: employing and avoiding epigenetic processes. Genes Dev (2009) 2.26
MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol Immunol (2007) 2.24
Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet (2007) 2.22
Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J (2003) 2.21
Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression. J Biol Chem (2003) 2.15
DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma (2009) 2.13
Active repression of methylated genes by the chromosomal protein MBD1. Mol Cell Biol (2000) 2.12
HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins. EMBO J (2000) 2.11
Cancer biology and NuRD: a multifaceted chromatin remodelling complex. Nat Rev Cancer (2011) 2.10
Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1). Mol Cell Biol (2002) 2.06
VIM1, a methylcytosine-binding protein required for centromeric heterochromatinization. Genes Dev (2007) 2.01
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci U S A (1999) 1.99
Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol (2000) 1.98
Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc Natl Acad Sci U S A (2001) 1.93
Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. J Cell Biol (2005) 1.91
MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad Sci U S A (2003) 1.83
Interpreting the language of histone and DNA modifications. Biochim Biophys Acta (2014) 1.80
The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res (2004) 1.79
Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation. Proc Natl Acad Sci U S A (2002) 1.77
DNA methylation and its basic function. Neuropsychopharmacology (2012) 1.76
Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms. Mol Cell Biol (1999) 1.75
Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains. Mol Cell Biol (2004) 1.74
Molecular mechanisms of gene silencing mediated by DNA methylation. Mol Cell Biol (2002) 1.73
CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2). J Virol (2005) 1.72
5-Methylcytosine DNA glycosylase activity is also present in the human MBD4 (G/T mismatch glycosylase) and in a related avian sequence. Nucleic Acids Res (2000) 1.71
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status. Br J Cancer (2003) 1.71
Comparative study of methyl-CpG-binding domain proteins. BMC Genomics (2003) 1.70
Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation. Mol Cell Biol (2001) 1.70
Kaiso-deficient mice show resistance to intestinal cancer. Mol Cell Biol (2006) 1.67
Dynamic analysis of proviral induction and De Novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression. Mol Cell Biol (2000) 1.67
The versatile thymine DNA-glycosylase: a comparative characterization of the human, Drosophila and fission yeast orthologs. Nucleic Acids Res (2003) 1.67
Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res (2001) 1.64
Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. Mol Cell Biol (2002) 1.64
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res (2006) 1.58
Epigenetic alterations in human prostate cancers. Endocrinology (2009) 1.55
Three SRA-domain methylcytosine-binding proteins cooperate to maintain global CpG methylation and epigenetic silencing in Arabidopsis. PLoS Genet (2008) 1.54
Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Mol Cell Biol (2000) 1.53
A Bayesian hierarchical model to detect differentially methylated loci from single nucleotide resolution sequencing data. Nucleic Acids Res (2014) 1.52
A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol (2013) 1.50
Distinctive higher-order chromatin structure at mammalian centromeres. Proc Natl Acad Sci U S A (2001) 1.47
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol Cell Biol (2002) 1.46
Retracted Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression. Mol Cell Biol (2006) 1.45
Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet (2010) 1.44
DNA demethylation. Proc Natl Acad Sci U S A (1999) 1.43
Targeting polycomb to pericentric heterochromatin in embryonic stem cells reveals a role for H2AK119u1 in PRC2 recruitment. Cell Rep (2014) 1.43
Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am J Hum Genet (2002) 1.42
Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. J Med Genet (2003) 1.40
Imprinting and epigenetic changes in the early embryo. Mamm Genome (2009) 1.40
Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin? Cell Mol Life Sci (2008) 1.39
Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Mol Cancer (2006) 1.38
The MBD protein family-reading an epigenetic mark? Mutat Res (2008) 1.38
Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet (2006) 1.37
The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA. PLoS One (2010) 1.37
Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res (2000) 1.37
Engineering a high-affinity methyl-CpG-binding protein. Nucleic Acids Res (2006) 1.36
The MIRA method for DNA methylation analysis. Methods Mol Biol (2009) 1.35
Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma. J Biol Chem (2002) 1.35
MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. Nucleic Acids Res (2000) 1.34
Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor. Nucleic Acids Res (2001) 1.34
Physiological roles of class I HDAC complex and histone demethylase. J Biomed Biotechnol (2010) 1.33
A novel method for the efficient and selective identification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res (2011) 1.32
Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood (2007) 1.31
Cause and consequences of genetic and epigenetic alterations in human cancer. Curr Genomics (2008) 1.31
BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J Virol (2005) 1.30
DNA methylation profiling using the methylated-CpG island recovery assay (MIRA). Methods (2010) 1.30
The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16(INK4a) and hMLH1 genes. Mol Cell Biol (2005) 1.30
DNA glycosylases: in DNA repair and beyond. Chromosoma (2011) 1.29
Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis. Proc Natl Acad Sci U S A (2003) 1.29
Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter. Nucleic Acids Res (2000) 1.28
The epigenome as a therapeutic target in prostate cancer. Nat Rev Urol (2010) 1.28
Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med (Maywood) (2011) 1.27
Proteins that bind methylated DNA and human cancer: reading the wrong words. Br J Cancer (2008) 1.27
Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA. Nucleic Acids Res (2010) 1.26
Reduced genomic cytosine methylation and defective cellular differentiation in embryonic stem cells lacking CpG binding protein. Mol Cell Biol (2005) 1.26
Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics (2010) 1.26
Permissive transcriptional activity at the centromere through pockets of DNA hypomethylation. PLoS Genet (2006) 1.26
Solution structure and dynamic analysis of chicken MBD2 methyl binding domain bound to a target-methylated DNA sequence. Nucleic Acids Res (2011) 1.26
Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol Cell Biol (2007) 1.25
Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J (2001) 1.25
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell (1986) 42.45
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell (1992) 27.80
CpG-rich islands and the function of DNA methylation. Nature (1986) 24.90
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet (1998) 13.27
Role for DNA methylation in genomic imprinting. Nature (1993) 12.65
The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics (1996) 11.71
Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell (1991) 8.85
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A (1994) 8.47
Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell (1992) 8.10
De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development (1996) 7.98
Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature (1988) 7.61
High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell (1990) 7.45
Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A (1993) 6.79
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell (1997) 6.45
DNA methylation and gene activity. Cell (1988) 5.90
Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell (1989) 5.12
CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev (1989) 5.00
DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell (1991) 4.90
Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res (1993) 4.30
Genomic imprinting in mammals. Annu Rev Genet (1997) 4.21
Gene number, noise reduction and biological complexity. Trends Genet (1995) 4.19
X-chromosome inactivation and cell memory. Trends Genet (1992) 3.76
CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res (1990) 3.46
Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J (1992) 3.43
DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol (1996) 3.10
5-Methylcytosine localised in mammalian constitutive heterochromatin. Nature (1974) 3.06
DNA methylation and genomic imprinting. Cell (1994) 2.51
Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet (1991) 2.45
A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins. Nat Genet (1997) 2.43
Chromatin structure is required to block transcription of the methylated herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci U S A (1987) 2.35
Comparative genomics, genome cross-referencing and XREFdb. Trends Genet (1995) 2.35
Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells. Proc Natl Acad Sci U S A (1995) 2.35
The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc Natl Acad Sci U S A (1988) 2.14
Loss of methylation activates Xist in somatic but not in embryonic cells. Genes Dev (1995) 2.08
The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet (1996) 1.93
Methylation of genomes and genes at the invertebrate-vertebrate boundary. Mol Cell Biol (1997) 1.92
Inactive chromatin spreads from a focus of methylation. Mol Cell Biol (1993) 1.83
Chicken MAR-binding protein ARBP is homologous to rat methyl-CpG-binding protein MeCP2. Mol Cell Biol (1997) 1.68
Multiple roles for DNA methylation in gametic imprinting. Curr Opin Genet Dev (1996) 1.26
xUBF, an RNA polymerase I transcription factor, binds crossover DNA with low sequence specificity. Mol Cell Biol (1994) 1.26
The relationship of DNA methylation to cancer. Cancer Surv (1996) 1.23
Isolation of novel tissue-specific genes from cDNA libraries representing the individual tissue constituents of the gastrulating mouse embryo. Development (1995) 1.13
A methylation-dependent DNA-binding activity recognising the methylated promoter region of the mouse Xist gene. Biochem Biophys Res Commun (1997) 0.97
Rapid cDNA sequencing in combination with RNA expression studies in mice identifies a large number of male germ cell-specific sequence tags. Biol Reprod (1995) 0.96
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (1998) 18.36
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet (2001) 9.82
Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell (1992) 8.10
Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev (1999) 7.58
High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell (1990) 7.45
Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A (1993) 6.79
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell (1997) 6.45
A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell (1985) 5.63
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet (1999) 5.61
DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell (1991) 4.90
The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature (1999) 4.63
Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res (1993) 4.30
Alternative chromatin structure at CpG islands. Cell (1990) 3.93
The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. Proc Natl Acad Sci U S A (1990) 3.56
Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J (1992) 3.43
Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev (2001) 3.41
A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet (1996) 3.31
DNA methylation and chromatin modification. Curr Opin Genet Dev (1999) 3.14
DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol (1996) 3.10
Histone deacetylases: silencers for hire. Trends Biochem Sci (2000) 3.02
The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev (2001) 2.91
The Iowa Articulation Norms Project and its Nebraska replication. J Speech Hear Disord (1990) 2.78
A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins. Nat Genet (1997) 2.43
Does DNA methylation control transposition of selfish elements in the germline? Trends Genet (1997) 2.22
Initiation of DNA replication at CpG islands in mammalian chromosomes. EMBO J (1998) 2.13
Active repression of methylated genes by the chromosomal protein MBD1. Mol Cell Biol (2000) 2.12
CpG islands as genomic footprints of promoters that are associated with replication origins. Curr Biol (1999) 2.02
The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat Genet (1996) 1.93
Methylation of genomes and genes at the invertebrate-vertebrate boundary. Mol Cell Biol (1997) 1.92
Localization of two genes for Usher syndrome type I to chromosome 11. Genomics (1992) 1.90
DNA methylation and chromatin structure. FEBS Lett (1991) 1.90
Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res (1989) 1.87
Nonmethylated transposable elements and methylated genes in a chordate genome. Science (1999) 1.75
Coincident start sites for divergent transcripts at a randomly selected CpG-rich island of mouse. EMBO J (1987) 1.68
Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene (1999) 1.55
Loss of rDNA methylation accompanies the onset of ribosomal gene activity in early development of X. laevis. Cell (1981) 1.52
The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation. Health Technol Assess (2010) 1.51
Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. Mamm Genome (1999) 1.44
Vestiges of a DNA methylation system in Drosophila melanogaster? Nat Genet (1999) 1.44
Compact sources as the origin of the soft gamma-ray emission of the Milky Way. Nature (2004) 1.41
Mutations in the RP1 gene causing autosomal dominant retinitis pigmentosa. Hum Mol Genet (1999) 1.35
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther (2006) 1.35
An alternative promoter in the mouse major histocompatibility complex class II I-Abeta gene: implications for the origin of CpG islands. Mol Cell Biol (1998) 1.34
Densely methylated sequences that are preferentially localized at telomere-proximal regions of human chromosomes. Gene (1999) 1.33
Cloning and characterization of a gene involved in phytoene synthesis from tomato. Plant Mol Biol (1992) 1.31
Mammalian methyltransferases and methyl-CpG-binding domains: proteins involved in DNA methylation. Curr Top Microbiol Immunol (2000) 1.31
DNAase I sensitivity and methylation of active versus inactive rRNA genes in xenopus species hybrids. Cell (1982) 1.30
Gene number in an invertebrate chordate, Ciona intestinalis. Proc Natl Acad Sci U S A (1998) 1.27
Gene silencing by methyl-CpG-binding proteins. Novartis Found Symp (1998) 1.26
dSIR2 and dHDAC6: two novel, inhibitor-resistant deacetylases in Drosophila melanogaster. Exp Cell Res (2001) 1.24
Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Hematol (1987) 1.23
CpG islands. EXS (1993) 1.23
Ribosomal RNA gene amplification by rolling circles. J Mol Biol (1974) 1.20
The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome. Brain Dev (2001) 1.19
Mosaic methylation of the repeat unit of the human ribosomal RNA genes. Hum Mol Genet (1997) 1.19
Absence of genome-wide changes in DNA methylation during development of the zebrafish. Nat Genet (1999) 1.17
DNaseI-hypersensitive sites at promoter-like sequences in the spacer of Xenopus laevis and Xenopus borealis ribosomal DNA. Nucleic Acids Res (1983) 1.13
Role of MBD2 in gene regulation and tumorigenesis. Biochem Soc Trans (2005) 1.12
Epidemiology of age-related macular degeneration. Mol Vis (1999) 1.11
Changes in Bruch's membrane and related structures with age. Prog Retin Eye Res (1999) 1.10
Transcriptional repression by methylation of CpG. J Cell Sci Suppl (1992) 1.08
An analysis of ABCR mutations in British patients with recessive retinal dystrophies. Invest Ophthalmol Vis Sci (2000) 1.08
Sequence analysis of transposable elements in the sea squirt, Ciona intestinalis. Mol Biol Evol (2000) 1.07
Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health Technol Assess (2010) 1.06
Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD. Eye (Lond) (2011) 1.06
Immortalization of conditionally transformed chicken cells: loss of normal p53 expression is an early step that is independent of cell transformation. Genes Dev (1992) 1.05
Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia. Mol Ther (2007) 1.05
The origin of the rRNA precursor from Xenopus borealis, analysed in vivo and in vitro. Nucleic Acids Res (1983) 1.04
Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type Ia, with adeno-associated virus (AAV) vectors. Gene Ther (2002) 1.04
Coupled demethylation of sites in a conserved sequence of Xenopus ribosomal DNA. Cold Spring Harb Symp Quant Biol (1983) 1.03
Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria. Gene Ther (2006) 1.02
Transcription in oocytes of highly methylated rDNA from Xenopus laevis sperm. Nature (1984) 1.01
Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures. J Clin Invest (1989) 1.00
A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population. Psychol Med (1996) 0.97
A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration. Health Technol Assess (2008) 0.94
Non-methylated islands in fish genomes are GC-poor. Nucleic Acids Res (1991) 0.93
Binding of histone H1 to DNA is indifferent to methylation at CpG sequences. J Biol Chem (1995) 0.93
Hepatitis C virus infection rate in volunteer blood donors from the Western Cape--comparison of screening tests and PCR. S Afr Med J (1997) 0.92
A portable instrument for measuring macular pigment with central fixation. Curr Eye Res (2002) 0.91
Reduced seizure threshold and altered network oscillatory properties in a mouse model of Rett syndrome. Neuroscience (2012) 0.90
Predicting the total number of human genes. Nat Genet (1994) 0.90
Increasing patient participation using an extended consultation: an inner city study. J R Coll Gen Pract (1988) 0.89
Is gene amplification RNA-directed? Nat New Biol (1973) 0.88
What do you work with? Br Med J (Clin Res Ed) (1985) 0.87
Molecular hybridization of 3H-labelled ribosomal RNA with DNA in ultrathin sections prepared for electron microscopy. Biochim Biophys Acta (1971) 0.87
Primary tuberculosis of the conjunctiva. Br J Ophthalmol (1967) 0.86
Successful conservative management of inversion of a fibroid uterus by hydrostatic balloon. J Obstet Gynaecol (2010) 0.85
Age-related macular disease. Br J Ophthalmol (1996) 0.85
Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review. Vox Sang (2012) 0.84
Rational modulation of the catalytic activity of A1-1 glutathione S-transferase: evidence for incorporation of an on-face (pi...HO-Ar) hydrogen bond at tyrosine-9. Biochemistry (1996) 0.81
Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease. Gene Ther (2010) 0.81
Two new rhodopsin transversion mutations (L40R; M216K) in families with autosomal dominant retinitis pigmentosa. Hum Mutat (1994) 0.80
Indomethacin for patent ductus arteriosus closure. Application of serum concentrations and pharmacodynamics to improve response. J Perinatol (1990) 0.79
Day-time naps and melatonin in blind people. Lancet (1995) 0.79
The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation. Health Technol Assess (2010) 0.79
Structure and expression of the chicken retinoblastoma gene. Cell Growth Differ (1994) 0.78
Expression of the first N-glycosylation gene in the dolichol pathway, ALG7, is regulated at two major control points in the G1 phase of the Saccharomyces cerevisiae cell cycle. Exp Cell Res (1995) 0.78
The dual role of mRNA half-lives in the expression of the yeast ALG7 gene. Mol Cell Biochem (1997) 0.78
Cytotoxic interactions of tumor necrosis factor, melphalan and 41.8 degrees C hyperthermia. Cancer Lett (1995) 0.77
Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation. Health Technol Assess (2011) 0.77